The global embolization particle market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of benign prostatic hyperplasia (BPH) and uterine fibroid embolization (UFE), growing demand for minimally invasive procedures, and rising adoption of embolic agents in various applications. The microspheres segment accounted for the largest share in the global embolization particle market in 2018, followed by particles segment. The microspheres segment is expected to maintain its dominance throughout the forecast period owing to their ability to be used as an alternative treatment option for various conditions such as BPH and UFE. In terms of application, UFE accounted for the largest share in 2018 due to its high prevalence among women aged 40-50 years old and increasing adoption rates across developed countries such as US and Japan. However, liver tumor embolization (LTE) is projected to grow at a higher CAGR during the forecast period owing to its high incidence rate among men aged 50-60 years old with chronic liver disease or cirrhosis who are more likely than women with uterine fibroids or benign prostatic hyperplasia (BPH) are more likely than women with uterine fibroids or benign prostatic hyperplasia (BPH) are more likely than women with uterine fibroids or benign prostatic hyperplasia (BPH) are more likely than women with uterine fibroids or benign prostatic hyperplasia (BPH).
- The market for embolization particles is expected to reach $1,890 million by 2025.
- Increasing prevalence of cancer and other diseases will drive the growth of the embolization particle market.
- Increasing number of new product launches in the global embolization particle market will fuel its growth.
- Growing demand for minimally invasive procedures.
Industry Growth Insights published a new data on “Embolization Particle Market”. The research report is titled “Embolization Particle Market research by Types (Microspheres, Particles (e.g. PVA Particles, Gelfoam Particles), Drug-eluting Beads (DEBs), Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)), By Applications (Uterine Fibroid Embolization, Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH), Liver Tumor Embolization, Trauma Embolization, Other), By Players/Companies Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical, INterface BIOmaterials B.V., Alicon”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Embolization Particle Market Research Report
By Type
Microspheres, Particles (e.g. PVA Particles, Gelfoam Particles), Drug-eluting Beads (DEBs), Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
By Application
Uterine Fibroid Embolization, Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH), Liver Tumor Embolization, Trauma Embolization, Other
By Companies
Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical, INterface BIOmaterials B.V., Alicon
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Embolization Particle Market Report Segments:
The global Embolization Particle market is segmented on the basis of:
Types
Microspheres, Particles (e.g. PVA Particles, Gelfoam Particles), Drug-eluting Beads (DEBs), Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Uterine Fibroid Embolization, Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH), Liver Tumor Embolization, Trauma Embolization, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sirtex Medical
- Merit Medical
- Cook Medical
- BTG Medical
- Boston Scientific Corporation
- Terumo Corporation
- HENGRUI Medical
- INterface BIOmaterials B.V.
- Alicon
Highlights of The Embolization Particle Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Microspheres
- Particles (e.g. PVA Particles, Gelfoam Particles)
- Drug-eluting Beads (DEBs)
- Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
- By Application:
- Uterine Fibroid Embolization
- Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
- Liver Tumor Embolization
- Trauma Embolization
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Embolization Particle Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
An embolization particle is a small, solid piece of material that is used to block blood flow in an artery or vein.
Some of the key players operating in the embolization particle market are Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical, INterface BIOmaterials B.V., Alicon.
The embolization particle market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Embolization Particle Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Embolization Particle Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Embolization Particle Market - Supply Chain
4.5. Global Embolization Particle Market Forecast
4.5.1. Embolization Particle Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Embolization Particle Market Size (000 Units) and Y-o-Y Growth
4.5.3. Embolization Particle Market Absolute $ Opportunity
5. Global Embolization Particle Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Embolization Particle Market Size and Volume Forecast by Type
5.3.1. Microspheres
5.3.2. Particles (e.g. PVA Particles, Gelfoam Particles)
5.3.3. Drug-eluting Beads (DEBs)
5.3.4. Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Embolization Particle Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Embolization Particle Market Size and Volume Forecast by Application
6.3.1. Uterine Fibroid Embolization
6.3.2. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
6.3.3. Liver Tumor Embolization
6.3.4. Trauma Embolization
6.3.5. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Embolization Particle Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Embolization Particle Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Embolization Particle Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Embolization Particle Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Embolization Particle Demand Share Forecast, 2019-2026
9. North America Embolization Particle Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Embolization Particle Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Embolization Particle Market Size and Volume Forecast by Application
9.4.1. Uterine Fibroid Embolization
9.4.2. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
9.4.3. Liver Tumor Embolization
9.4.4. Trauma Embolization
9.4.5. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Embolization Particle Market Size and Volume Forecast by Type
9.7.1. Microspheres
9.7.2. Particles (e.g. PVA Particles, Gelfoam Particles)
9.7.3. Drug-eluting Beads (DEBs)
9.7.4. Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Embolization Particle Demand Share Forecast, 2019-2026
10. Latin America Embolization Particle Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Embolization Particle Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Embolization Particle Market Size and Volume Forecast by Application
10.4.1. Uterine Fibroid Embolization
10.4.2. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
10.4.3. Liver Tumor Embolization
10.4.4. Trauma Embolization
10.4.5. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Embolization Particle Market Size and Volume Forecast by Type
10.7.1. Microspheres
10.7.2. Particles (e.g. PVA Particles, Gelfoam Particles)
10.7.3. Drug-eluting Beads (DEBs)
10.7.4. Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Embolization Particle Demand Share Forecast, 2019-2026
11. Europe Embolization Particle Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Embolization Particle Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Embolization Particle Market Size and Volume Forecast by Application
11.4.1. Uterine Fibroid Embolization
11.4.2. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
11.4.3. Liver Tumor Embolization
11.4.4. Trauma Embolization
11.4.5. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Embolization Particle Market Size and Volume Forecast by Type
11.7.1. Microsphres
11.7.2. Particles (e.g. PVA Particles, Gelfoam Particles)
11.7.3. Drug-eluting Beads (DEBs)
11.7.4. Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Embolization Particle Demand Share, 2019-2026
12. Asia Pacific Embolization Particle Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Embolization Particle Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Embolization Particle Market Size and Volume Forecast by Application
12.4.1. Uterine Fibroid Embolization
12.4.2. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
12.4.3. Liver Tumor Embolization
12.4.4. Trauma Embolization
12.4.5. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Embolization Particle Market Size and Volume Forecast by Type
12.7.1. Microspheres
12.7.2. Particles (e.g. PVA Particles, Gelfoam Particles)
12.7.3. Drug-eluting Beads (DEBs)
12.7.4. Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Embolization Particle Demand Share, 2019-2026
13. Middle East & Africa Embolization Particle Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Embolization Particle Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Embolization Particle Market Size and Volume Forecast by Application
13.4.1. Uterine Fibroid Embolization
13.4.2. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
13.4.3. Liver Tumor Embolization
13.4.4. Trauma Embolization
13.4.5. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Embolization Particle Market Size and Volume Forecast by Type
13.7.1. Microspheres
13.7.2. Particles (e.g. PVA Particles, Gelfoam Particles)
13.7.3. Drug-eluting Beads (DEBs)
13.7.4. Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Embolization Particle Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Embolization Particle Market: Market Share Analysis
14.2. Embolization Particle Distributors and Customers
14.3. Embolization Particle Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Sirtex Medical
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Merit Medical
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Cook Medical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. BTG Medical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Boston Scientific Corporation
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Terumo Corporation
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. HENGRUI Medical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. INterface BIOmaterials B.V.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Alicon
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook